Home | Survey | Payment| Talks & Presentations | Job Opportunities
Journals   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
International Journal of Ophthalmology
1672-5123
2003 Issue 1
TRANSSCLERAL DIODE LASER CONTACT CYCLOPHOTOCOAGULATION IN THE TREATMENT OF HIGH RISK
Berumen-Alatorre;M.E.Gilbert-Lucido;N.D.C.Ruiz-Quintero;F.Berumen-Alatorre
..............page:122-123
INTRA-OCULAR PRESSURE CHANGES AFTER B-BLOCKER EYE DROPS INSTILLATION AND BICYCLE ERGOMETER EXERCISE
V.E.Karabatakis;T.E.Chatzibalis;K.A.Kallinderis;I.T.Bisbas;K.I.Natsis;A.Doudou;S.G.Diafas;A.Vermoud;N.T.Stangos
..............page:122-122
REACHING TARGET IOP: OPTIMAL MEDICAL MANAGEMENT
I.Goldberg
..............page:122-122
NEW QUALITY ASSESSMENT PARAMETERS FOR OCT 3
H.Ishikawa;R.Hariprasad;G.Wollstein;L.A.Paunescu;L.L.Price;P.Stark;J.G.Fujimoto;J.S.Schuman
..............page:121-122
CORNEAL THICKNESS IN GLAUCOMA DIAGNOSIS AND MANAGEMENT
J.D.Brandt
..............page:121-121
TREATMENT OF OCULAR HYPERTENSION
R.Weinreb
..............page:121-121
PROSTAMIDE PHARMACOLOGY: A NEW CLASS OF IOP-LOWERING AGENTS
A.H-P.Krauss;D.F.Woodward
..............page:121-121
EFFICACY OF PROSTAGLANDINS IN THE EYE
R.K.Parrish
..............page:120-120
THE HISTOLOGICAL STUDY OF CONJONCTIVA AFTER SHORT AND LONG-TERM TOPICAL ANTIGLAUCOMA TREATMENT
S.Moulessehoul;H.Mehida;Y.Zidi;M.Benali
..............page:120-120
INNOVATIVE SURGICAL MANAGEMENT OF NEOVASCULAR GLAUCOMA
G.K.Krieglstein
..............page:120-120
ACHIEVING POWERFUL IOP CONTROL IN CLINICAL PRACTICE
W.C.Stewart
..............page:120-120
VASCULAR EFFECTS OF PROSTAGLANDINS IN THE EYE
J.W.Stjernschantz
..............page:119-120
EARLY MANIFEST GLAUCOMA TREATMENT STUDY
P.L.Kaufman
..............page:119-119
IDENTIFYING THE TARGETS FOR GLAUCOMA CARE
C.E.Traverso
..............page:119-119
OPTIC NERVE HEAD ANALYSIS
J.S Schuman
..............page:118-118
WHY NOT LASER TO SC AB EXTERNO?
J.S.Schuman
..............page:118-118
CIGTS: COLLABORATIVE INITIAL GLAUCOMA TREATMENT STUDY
J.Liebmann
..............page:118-118
TOPOGRAPHIC MEASUREMENTS OF RETINAL VASCULATURE WITH A SCANNING LASER OPHTHALMOSCOPE IN PRIMARY OPEN ANGLE GLAUCOMA
P.H.Galloway;F.S.Mikelberg;N.V.Swindale
..............page:118-118
THE ADVANCED GLAUCOMA INTERVENTION STUDY
P.F.Palmberg
..............page:117-118
RETINAL ARTERIOLAR OBSTRUCTION IN A PATIENT WITH SICKLE CELL TRAIT AND GLAUCOMA SECONDARY TO TRAUMATIC HYPHEMA
M.Shalem;A.Wolf;O.Geyer
..............page:117-117
LONG-TERM SAFETY OF PROSTAGL ANDINS IN THE EYE
A.Alm
..............page:117-117
TRENDS IN GLAUCOMA MANAGEMENT
G.L.Spaeth
..............page:117-117
OHTS: IMPLICATIONS FOR CLINICAL PRACTICE
M.R.Wilson
..............page:116-117
MORPHOLOGY OF SCHLEMM′S CANAL IN NORMAL AND GLAUCOMATOUS PATIENTS
A.Mermoud
..............page:114-114
SELECTIVE LASER TRABECULOPLASTY (SLT) VS. ARGON LASER TRABECULOPLASTY (ALT) -3 YEAR FOLLOW-UP
K.F.Damji;A.M.Bovell;W.G.Hodge;W.Rock;R.Buhrmann
..............page:114-114
GLAUCOMA AFTER PENETRATING KERATOPLASTY IN CASE OF KERATOCONUS
L.S.Legkikh;V.G.Kopayeva;A.L.Semenova
..............page:114-115
A DIURNAL EVALUATION OF IOP IN PATIENTS TREATED WITH TRAVATAN OR XALATAN
H.DuBiner;M.Ratlifi;T.Landry;F.Turner;S.M.Robertson;R.M.Andrews;A.L.Weiner;J.Pryzdryga
..............page:115-115
GLAUCOMA IN PATIENTS WITH LONG TERM PRESCRIPTION OF INHALED STEROIDS
U.Weitgasser;M.Trinker
..............page:115-115
WHAT CAUSES RETINAL GANGLION CELLS TO DIE? NEUROTOXICITY AND NEUROPROTECTION
H.A.Quigley
..............page:115-116
LESSONS ABOUT GLAUCOMA FROM PREVALENCE STUDIES
H.A.Quigley
..............page:116-116
MAKING SENSE OF CLINICAL TRIALS IN GLAUCOMA -GLAUCOMA LASER TRIAL(GLT)
R.Parrish
..............page:116-116
MUSCARINIC BLOCKERS POTENTIATE BETA-ADRENERGIC RELAXATION OF BOVINE IRIS SPHINCTER
Y.Oron;A.Barilan;R.Nachman-Rubinstein;O.Geyer
..............page:116-116
ZINC ATTENUATES AND EXACERBATES RETINAL NEURONAL DEATH DEPENDING ON CONCENTRATION
N.N.Osborne
..............page:107-107
RETINAL THICKNESS ANALYSIS IN UVEITIC GLAUCOMA
J.D.Sheppard;B.I.Bodner;S.V.Scoper
..............page:123-123
HEMIVEIN PULSATION CHANGES CORRELATE WITH SITE OF VISUAL FIELD LOSS IN GLAUCOMA
W.H.Morgan;M.L.Hazelton;C.Balaratnasingem;P.H.House;D-Y.Yu;S.J.Cringle;R.Townsend
..............page:123-123
THE EX-PRESS MINIATURE GLAUCONMA IMPLANT IN COMBINED SURGERY WITH CATARACT EXTRACTION: PROSPECTIVE STUDY
A.Mermoud;D.Rivier
..............page:106-107
THE EFFECT OF VARIOUS ANTIGLAUCOMATOUS DRUGS ON SUBCONJUNTIVAL FIBROBLAST CELL CULTURE
I.Yucel;Y.Akar;G.Bagci
..............page:106-106
BIOCHEMISTRY OF EXFOLIATION SYNDROME
A.G.P.Konstas
..............page:106-106
PATHOBIOLGY OF EXFOLIATION SYNDROME
U.Schloetzer-Schrehardt
..............page:105-106
THE OHTS STUDY: WE CAN PREVENT GLAUCOMA PROGRESSION WITH A MODERATE IOP REDUCTION
G.Carella
..............page:102-102
GLAUCOMA PROFILING: TAILORING THERAPY TO OPTIMALLY BALANCE EFFICACY SAFETY AND TOLERABILITY
K.Singh
..............page:102-102
THE MEDICAL MANAGEMENT OF GLAUCOMA: HOW TO CHOOSE FIRST-LINE THERAPY
P.N.Schacknow
..............page:114-114
ADVANCES IN MANAGEMENT OF COEXISTING CATARACT AND GLAUCOMA
F.El Sayyad
..............page:113-114
SYSTEMIC MANIFESTATIONS OF EXFOLIATION SYNDROME
R.Vessani
..............page:101-101
IS EXFOLIATION SYNDROME AN INFECTIOUS DISEASE?
J.Liebmann
..............page:101-101
THE INTERNATIONAL COLLABORATIVE EXFOLIA TION SYNDROME TREATMENT (ICEST) STUDY
T.Krupin
..............page:101-101
OVERVIEW OF EXFOLIATION SYNDROME
R.Ritch
..............page:100-101
USE OF ETHACRYNIC ACID (ECA) AS AN ADJUNCTIVE THERAPY IN (NPDS)
S.Melamed
..............page:100-100
SELECTIVE LASER TRABECULOPLASTY (SLT) AS PRIMARY TREATMENT FOR OPEN ANGLE GLAUCOMA. A PROSPECTIVE NON-RANDOMIZED PILOT STUDY
S.Melamed;G.J.Ben Simon;H.Levkovitz-Verbin
..............page:99-100
THE NEW EUROPEAN GUIDELINES FOR GLAUCOMA
J.Thygesen
..............page:99-99
THE PREVALENE OF PRIMARY OPEN ANGLE GLAUCOMA (POAG) IN ITALY
G.L.Scuderi;C.Cedrone;C.Nucci;G.Macrì;C.Moretto;L.Cerulli
..............page:99-99
NON-PENETRATING DEEP SCLERECTOMY WICH DRAINAGE SCHLEMM′S CANAL IN THE TREATMENT OF PRIMARY OPEN-ANGLE GLAUCOMA
V.Machehin;S.Nicolashin
..............page:98-99
TWENTY-FOUR HOUR DIURNAL CURVE COMPARISON OF COMMERCIALLY AVAILABLE BIMATOPROST 0.03% VERSUS TIMOLOL MALEATE 0.5%/DORZOLAMIDE 2% FIXED COMBINATION
D.G.Day;E.D.Sharpe;C.J.Beischel;J.N.Leech;J.A.Stewart;W.C.Stewart
..............page:98-98
BRIMONIDINE % 0.2 CAN PREVENT THE HYPEREMIA INDUCED BY TRAVOPROST 0.004%
U.Inan;F.Ozturk;S Ermis;A.Asagidag
..............page:98-98
OPTINEURIN SEQUENCE VARIANTS IN BRITISH GLAUCOMA SUBJECTS
T.Aung;N.Ebenezer;G.Brice;A.Child;R.Hitchings;O.Lehmann;S.Bhattacharya
..............page:97-98
THE CORRELATION OF PACHIMETRIC KERATOMETRIC AND BIOMETRIC MEASUREMENTS WITH INTRAOCULAR PRESSURE IN HEALTHY SUBJECTS
U.U.Inan;S.S.Ermis;F.Ozturk;S.Ildan;A.Asagidag
..............page:97-97
CLINICAL AND THEORETIC BASIS FOR SUCCESS OF NON-PENETRATING GLAUCOMA SURGERY
T.V.Kozlova;K.E.Kotliar;J.G.Uzunian;V.V.Vasin
..............page:97-97
CURRENT RESEARCH IN GLAUCOMA MANAGEMENT
J.Thygesen
..............page:96-97
RECENT DEVELOPMENTS IN GENETICS AND GENOMICS
J.R.Samples
..............page:123-123
DYNAMIC CONTOUR TONOMETRY IN COMPARISON TO GOLDMANN APPLANATION TONOMETRY AND PNEUMOTO NOMETRY, A COMPARATIVE STUDY ON HUMAN CADAVER EYES
H.Kanngiesser;C.Kni-estedt;M.Nee;R.L.Stamper
..............page:108-108
IMPROVEMENT OF SCOTOPIC AND MESOPIC NIGHT-SEEING PERFORMANCE OF GLAUCOMA AFFECTED PATIENTS, WITH PROSTAGLANDIN′S AND b-BLOCKER TOPICALLY ADMINISTERED THERAPY
F.A.Cicirello;L.Marino;F.Marmo;S.Cicirello
..............page:108-108
PHACOEMULSIFICATION WITH A SMALL CORNEAL INCISION DECREASES INTRAOCULAR PRESSURE IN OPEN-ANGLE GLAUCOMA PATIENTS AND IN NORMAL CONTROLS
N.Mathalone;M.Hyams;S.Neiman;O.Geyer
..............page:107-108
MANAGEMENT OF LEAKING FILTERING BLEBS WITH THE DIODE LASER
E.Segev;O.Geyer
..............page:107-107
MAKING THE MOST OF DRAINAGE IMPLANTS IN GLAUCOMA TREATMENT
J.Freedman
..............page:107-107
CORRELATION BETWEEN RETINAL THICKNESS OCT-3 AND VISUAL FIELD IN GLAUCOMA
S.Asrani
..............page:96-96
IMPORTANCE OF CIRCADIAN IOP VARIATION
S.Asrani
..............page:95-96
ELECTROPHYSIOLOGICAL AND ANATOMICAL STUDIES ON THE EFFECTS OF RETINAL ISCHEMIA ON THE ERG AND ORTHOGRADE AXONAL TRANSPORT:NEUROPROTECTION WITH BRIMONIDINE
S.Mayor-Torroglosa;I.Igartua;A.Garcia;M.Lafuente;M.P.Villegas-Perez;P.De la Villa;M.Vidal-Sanz
..............page:95-95
NON-SYSTEMIC DELIVERY OF TOPICAL BRIMONIDINE TO THE BRAIN
M.Abdulrazik;S.Tamilvanan;S.Benita
..............page:95-95
EVALUATION OF CIRCADIAN INTRAOCULAR PRESSURE IN PATIENTS WITH GLAUCOMA OR OCULAR HYPERTENSION: THE BEHAVIOUR OF DIFFERENT ANTIGLAUCOMATOUS DRUGS
N.Orzalesi;L.Rossetti;A.Bottoli;P.Fogagnolo;E.Fumagalli
..............page:94-94
IN VITRO EFFECTS OF PRESERVED OR UNPRESERVED ANTIGLAUCOMA DRUGS ON APOPTOTIC MARKERS EXPRESSION BY HUMAN TRABECULAR CELLS
P.Hamard;C.Blondin;C. Debbasch;J.M.Warnet;F.Brignole;C.Baudouin
..............page:94-94
WELCOME & OPENING REMARKS
J.Garcia Sanchez
..............page:123-124
GLAUCOMA PROGRESSION: BEYOND IOP
A.Harris
..............page:124-124
EFFECTING OCULAR BLOOD FLOW
A.Martinez
..............page:124-125
SLT-SUMMARY AND FUTURE DIRECTIONS
M.Latina
..............page:125-125
NATURAL HISTORY OF OCCLUDABLE ANGLES AND PRIMARY ANGLE CLOSURE- KEY TO TREATMENT
R.Thomas;R.Parikh;R.George;J.P.Muliyel
..............page:105-105
HOW SCHLEMM′S CANAL SURGERY MIGHT WORK
M.Johnstone
..............page:105-105
THE EX-PRESSTM MINIATURE GLAUCOMA IMPLANT: LONG-TERM RESULTS
C.E.Traverso
..............page:104-104
EX-PRESS MINIATURE GLAUCOMA IMPLANT: IMPLANTATION UNDER A SCLERAL FLAP
E.Dahan;T.Carmichael
..............page:104-104
PROSTAMIDES ANANDAMIDE CYCLOOXYGENASE-2 METABOLITES: METABOLISM AND TRANSPORT STUDIES
V.Di Marzo;D.F.Woodward
..............page:104-104
DIFFERENTIAL RESPONSES TO BIMATOPROST AND PGF2ALPHA IN CAT IRIS SPHINCTER CELLS SUGGEST THE INVOLVEMENT OF DIFFERENT RECEPTORS
A.H.P.Krauss;C.S.Spada;D.F.Woodward;A.L.Nieves;L.A.Wheeler;D.Scott;G.Sachs
..............page:103-104
THE OCULAR HYPOTENSIVE EFFECTS OF LUMIGAN ARE UNRELATED TO METABOLITE FORMATION
D.F.Woodward;S.W.Andrews;R.M.Burk;M.E.Garst;J.Chen;A.H.P.Krauss;L.A.Wheeler;D.D.S.Tang-Liu;D.Welty;M.Cherukury
..............page:103-103
DIURNAL CONTROL OF INTRAOCULAR PRESSURE IN GLAUCOMA PATIENTS WITH SINGLE MORNING OR EVENING DOSE OF TIMOLOL GEL
C.H.Karabatsas;A.Sk-oufaras;M.A.Theodoridou;G.Koupidis;D.Z.Chatzoulis
..............page:103-103
NEW INSIGHT INTO MECHANISMS OF AQUEOUS OUTFLOW DEFICIENCY: ROLE OF THE STRESS RESPONSE
M.E.Fini;K.A.Erickson;E.L.Ginsberg;P.F.Olson;N.Wang;K.R.Wollenberg;X.Zhang;J.S.Schuman
..............page:102-102
THE USE OF MOLTENO IMPLANTS TO INVESTIGATE THE PATHOPHYSIOLOGY OF BLEB FORMATION WITH APPLICATION TO CLINICAL PRACTISE
A.Molteno
..............page:125-125
ABSENCE OF TRAVOPROST-INDUCED VS. LATANOPROST-INDUCED VASOCONSTRICTION IN ISOLATED PORCINE CILIARY ARTERIES: A PILOT STUDY
I.O.Haefliger;R.Allemann;G.Brogiolo;J.Flammer
..............page:113-113
WHY NOT LASER TO SC AB INTERO? ELT: EXCIMER LASER TRABECULOSTOMY
M.S.Berlin
..............page:113-113
SELECTIVE LASER TRABECULOPLASTY FOR COMPLICATED INFLAMMATORY GLAUCOMA
J.D.Sheppard;B.I.Bodner;S.V.Scoper
..............page:112-113
WHY NOT DRUG RX FOR JCT?
D.H.Johnson
..............page:112-112
PROTECTING THE RETINAL GANGLION CELL: A VIABLE STRATEGY
L.A.Levin
..............page:112-112
ECHOTHIOPHATE IODIDE FOR UNCONTROLLED GLAUCOMA IN APHAKIA AND PSEUDOPHAKIA
O.Geyer;E.Segev;E.Levinger
..............page:112-112
PRIMARY CONGENITAL GLAUCOMA PRESENTING WITHIN THE FIRST THREE MONTHS OF LIFE: PROGNOSTIC FACTORS
J.Levy;R.Carmi;S.Rosen;T.Lifshitz
..............page:111-111
SLT: UNDERLYING MECHANISMS
J.A.Alvarado
..............page:111-111
IMpORTANT DETAILS OF SC SURGERY (HOW TO ENTER SCHLEMM′S CANAL)
A.Mannelli
..............page:110-111
VISCOCANALOSTOMY: TECHNIQUE AND CLINICAL RESULTS
R.G.Carassa
..............page:110-110
ABNORMAL CEREBRAL VASCULAR AUTOREGULATION IN GLAUCOMA
D.Zarfati;J.Biller;C.W.Sheets;E.Rechtman
..............page:110-110
ANTERIOR PUPILLARY BLOCK-A RARE COMPLICATION OF MALIGNENT GLAUCOMA
Y.Yatziv;S.Kurtz;M.Lazar
..............page:110-110
LASER APPLICATIONS IN DEEP SCLERECTOMY OPERATIONS
I.Oge;F.Oge;N.Ariturk
..............page:109-110
THERAPEUTIC VACCINE FOR ARRESTING NEURONAL DEGENERATION IN GLAUCOMA
M.Schwartz
..............page:109-109
A TUBE INTO SC AB EXTERNO
S.Asrani;R.R.Allingham
..............page:109-109
WHY NOT OTHER CELLULAR THERAPIES?
J.A.Alvarado
..............page:108-109
TOPICALLY EFFECTIVE OPHTHALMIC SOLUTION OF ACETAZOLAMIDE- FUTURE PERSPECTIVE IN ANTIGLAUCOMA THERAPY
M.Gogia;M.Singh;I.P.Kaur
..............page:96-96
EFFECTS OF LATANOPROST AND BUNAZOSIN WHEN USED ALONE OR IN COMBINATION
K.Maruyama;S.Shirato;M.Hanede
..............page:91-91
GLAUCOMA IN FIRST DEGREE RELATIVES
M.Zalish;R.Pamess;A.Pollack;H.Katz;A.Harris;R.Rachmiel
..............page:91-91
CAN OPTIC NERVE HEMODYNAMICS PREDICT PROGRESSION OF GLAUCOMA?
J.E.Grunwald;J.Piltz;A.Staii;J.Zink;J.DuPont
..............page:82-82
THE RESULTS OF ONE -SITE VERSUS TWO- SITE APPROACHES IN COMBINED SURGERY (PHACOEMULSIFICATION AND TRABECULECTOMY)
Z.Kayaarasi;S.Bayraktar;H.Eren;A.Utine;O.F.Yilmaz
..............page:82-82
HISTOPATHOLOGIC STUDY OF CONJUNCTIV A IN PATIENTS WITH HYPEREMIA DURING BIMATOPROST THERAPY
B.C.Leal;F.A.Medeiros;F.W.Medeiros;R.M.Santo;R.Susanna Jr
..............page:81-82
RELEASABLE SUTURES IMPROVE THE OUTCOME OF TRABECULECTOMY
G.L.Spaeth;L.J.Katz;M.Makar;R.Shetty
..............page:81-81
TITANIUM SAPHIRE LASER TRABECULOPLASTY IN CATS
V.Fernadez;J.Stoiber;P.Lamar;E.Hernandez;F.Manns;N.Salas;F.Fantes;J.M.Parel
..............page:91-91
CURRENT STATUS OF COMBINED CATARACT AND GLAUCOMA PROCEDURES
K.F.Tomey
..............page:90-91
MINOCYCLINE HAS A NEUROPROTECTIVE EFFECT ON RETINAL GANGLION CELLS SURVIVAL AFTER OPTIC NERVE TRANSECTION IN RATS
H.Levkovitch-Verbin;G.Treister;Z.Vilner;S.Melamed
..............page:90-90
A NEW METHOD OF UTILIZING 5-FLUOROURACIL POSTOPERATIVELY THAT DECREASES CORNEAL COMPLICATIONS
G.L.Spaeth;P.T.Khaw
..............page:90-90
ADDITIVE EFFECTS OF CARTEOLOL AND NIPRADILOL WITH LATANOPROST ON INTRAOCULAR PRESSURE
M.Haneda;S.Shirato;K.Maruyama
..............page:89-90
THE EFFECT OF TRAVOPROST AND BIMATOPROST ON BLOOD FLOW VELOCITY OF THE RETROBULBAR VESSELS
F.Ozturk;U.Inan;A.Yucel;S.Ermis;A.Asagidag
..............page:89-89
IS THERE A RELATIONSHIP BETWEEN GLAUCOMA AND HELICOBA CTER PYLORI?
F.Ozturk;U.Inan;M.Altindis;S.Ermis;H.Dilek
..............page:89-89
GLTA FOR PRIMARY OPEN ANGLE GLAUCOMA USING A TITANIUM :SAPPHIRE LASER
G.Simon;J.A.Lowery
..............page:88-89
PATIENT PERSISTENCY WITH TOPICAL PROSTAGLANDIN THERAPY IN THE MANAGEMENT OF GLAUCOMA
G.F.Schwartz;G.Reardon;E.Mozaffari
..............page:88-88
CLINICAL AND ECONOMIC OUTCOMES OF LATANOPROST BIMATOPROST OR TRAVOPROST THERAPY IN GLAUCOMA PATIENTS: A THREE-MONTH RETROSPECTIVE STUDY
G.F.Schwartz;C.P.Schaefer;Y.C.Yeh;J.Nordin;E.Mozaffari
..............page:87-88
ANALYSIS OF ADHESION MOLECULE EXPRESSION IN TRABECULAR MESHWORK: A ROLE FOR INFLAMMATORY CELL ADHESION MOLECULES IN UVEITIC GLAUCOMA?
A.Bhan;P.Hossain;C.Flood;C.Nogueira;E.McDonald;H.Dua
..............page:87-87
OCULAR FUNDUS PULSATION AMPLITUDE AND SYSTEMIC BLOOD PRESSURE IN PATIENTS WITH GLAUCOMA AND OCULAR HYPERTENSION
G.Fuchsjaeger-Mayrl;G.Rainer;C.Vass;M.Georgopoulos;L.Schmetterer
..............page:77-77
THE DISC DAMAGE LIKELIHOOD SCORE A USEABLE TOOL IN THE DIAGNOSIS AND MANAGEMENT OF GLAUCOMA
G.L.Spaeth;J.D.Henderer;A.Bayer
..............page:77-77
CORNEAL TOPOGRAPHIC AND PACHYMETRIC CHANGES FOLLOWING TRABECULECTOMY
I.A.Fahmy;M.Khaled
..............page:77-77
COMPARISON OF OPTIC NERVE HEAD ASSESSMENT WITH A DIGITAL STEREOSCOPIC CAMERA (DISCAM) SCANNING LASER OPHTHALMOSCOPY AND STEREOGRAPHY
A.J.Correnti;G.Wollstein;L.L.Price;J.S.Schuman
..............page:76-77
LONGITUDINAL OPTICAL COHERENCE TOMOGRAPHY EVALUATION OF RETINAL NERVE FIBERLAYER THICKNESS IN GLAUCOMA PATIENTS
G.Wollstein;J.S.Schuman;L.L.Price;A.Aydin;P.C.Stark;E.Hertzmark;L.A.Paunescu;H.Ishikawa;C.Mattox;J.G.Fujimoto
..............page:87-87
DOES GLAUCOMA NEED AN UPDATE?
A.Wegner
..............page:86-87
UP REGULATION OF SEMAPHORIN EXPRESSION IN RETINA OF GLAUCOMATOUS RABBITS
A.S.Solomon;M.Kimron;V.Holdengreber;A.Shirvan;A.Barzilai
..............page:86-86
EFFECT OF NIMODIPINE ON OCULAR BLOOD FLOW AND COLOR CONTRAST SENSITIVITY IN PATIENTS WITH NORMAL TENSION GLAUCOMA
A.Luksch;G.Rainer;C.Vass;L.Schmetterer
..............page:82-83
CONJUNCTIVAL HISTOPATHOLOGICAL ANALISYS IN PATIENTS USING BIMATOPROST 0.03%
B.C.Leal;F.A.Medeiros;F.W.Medeiros;R.M.Santo;R.Susanna Jr
..............page:81-81
INTRAOCULAR PRESSURE OUTCOME IN PRIMARY 5FU PHACOTRABECULECTOMIES COMPARED TO 5FU TRABECULECTOMIES
L.Chang;M.Thiagarajan;S.Woodruff;C.Bentley;P.T.Khaw;P.Bloom
..............page:80-81
AN EVALUATION OF THE IOP CHANGES IN PATIENTS SWITCHED FROM BETA BLOCKER MONOTHERAPY OR COMBINATION THERAPY TO TRAVATAN IN THE S.T.A.R.T. TRIAL
P.Schacknow;J.T.Przydryga;Start Study Group
..............page:80-80
THEORETICAL CONSIDERATIONS CONCERNING POSTOPERATIVE AQUEOUS OUTFLOW AFTER GLAUCOMA SURGERY
K.E.Kotliar;T.V.Kozlova;I.M.Lanzl
..............page:80-80
COMPARISON OF LOCAL REACTIONS OF RETINAL ARTERIES AND VEINS IN RESPONSE TO INTRAOCULAR PRESSURE INCREASE IN NORMALS AND GLAUCOMA PATIENTS
I.M.Lanzl;E.Nagel;W.Vilser;K.E.Kotliar
..............page:79-80
AN ANALYSIS OF CHANGES IN IOP PATIENTS SWITCHED FROM LATANOPROST IN COMBINATION OR MNOTHERAPY TO TRAVOPROST IN THE S.T.A.R.T. TRIAL
P.Schacknow;Johan T.Przydryga;Start Study Group
..............page:79-79
SCLERAL WINDOW IN DEEP SCLERECTOMY: PRELIMINARY RESULTS
M.Figus;U.Benelli;M.P.Bartolomei;C.Ferretti;G.Guidi;M.Nardi
..............page:79-79
SYSTEMIC ARTERIAL HYPERTENSION AND PRIMARY OPEN ANGLE GLAUCOMA- GLAUCOMA PROJECT
K.Sakata;L.M.Sakata;V.M.Sakata;E.V.Wilckzek;F.Freire;F.Kakizaki
..............page:78-79
THE USE OF PROSTAGLANDINES′S DERIVATIVES HAS INFLUENCED THE COSTS OF GLAUCOMA TREATMENT? A RETROSPECTIVE ANALYSIS IN A POPULATION OF 2228 GLAUCOMA PATIENTS
R.de Natale;M.T.Dorigo;E.Draghi
..............page:72-72
GLAUCOMA: MEDICAL OR SURGICAL DISEASE? HOW THE PROSTAGLANDINES′ S DERIVATIVES HAVE MODIFIED GLAUCOMA TREATMENT
R.de Natale;M.T.Dorigo;E.Draghi
..............page:72-72
PEDIATRIC GLAUCOMAS: LONG-TERM OUTCOME OF CONGENITAL GLAUCOMA AND SECONDARY GLAUCOMA
M.S.Good;P.A.Quiram;D.O.Hodge;D.H.Johnson
..............page:78-78
CORRELATION OF SHORT-WAVELENGTH AUTOMATED PERIMETRY INDICES TO OPTIC DISC TOPOGRAPHY
J.M.U.Larrosa;A.Ferreras;V.Polo;A.Perez-Inigo;F.M.Honrubia
..............page:78-78
RANDOMIZED TRIAL COMPARING THE EFFECT OF BRIMONIDINE AND TIMOLOL ON VISUAL FIELD LOSS AFTER ACUTE PRIMARY ANGLE CLOSURE
H.T.Wong;T.Aung;F.T.S.Oen;Y.H.Chan;B.K.Khoo;Y.P.Lin;C.L.Ho;L.H.Thean;S.K.L.Seah;P.T.K.Chew
..............page:77-78
ANTI SEMA3A ANTIBODIES RESCUE RETINAL GANGLION CELLS FROM CELL DEATH FOLLOWING OPTIC NERVE AXOTOMY
A.Barzilai;A.Shirvan;M.Kimron;V.Holdengreber;I.Ziv;Y.Ben-Shaul;S.Melamed;E.Melamed;A.S.Solomon
..............page:86-86
A PROSPECTIVE RANDOMIZED COMPARATIVE STUDY BETWEEN ENDOSCOPIC CYCLOPHOTOCOAGULATION AND THE AHMED DRAINAGE IMPLANT IN REFRACTORY GLAUCOMA
F.E.Lima;L.Magacho;D.M.Carvalho;M.P.Avila;R.Susanna Jr
..............page:85-86
IN VITRO EFFECTS OF PRESERVED OR PRESERVATIVE-FREE ANTIGLAUCOMA MEDICATIONS ON HUMAN COMPLEMENT SYSTEM
C.Blondin;P.Hamard;B.Cholley;N.Haeffner-Cavaillon;C.Baudouin
..............page:85-85
LASER ASSISTED DEEP SCLERECTOMY(LADS). SURGICAL SUCCESS KEY FACTORS
C.Verges;E.Llevat;M.Cipres
..............page:85-85
VISUAL FIELD CHANGES IN PRIMARY OPEN-ANGLE AND NORMAL TENSION GLAUCOMA
M.A.Atanassov;M.I.Konareva-Kostianeva
..............page:52-53
IMPRESSION CYTOLOGY ANALYSIS OF HLA DR IL-6 AND IL-8 EXPRESSIONS BY CONJUNCTIVAL EPITHELIUM IN PATIENTS RECEIVING TOPICAL ANTIGLAUCOMA TREATMENTS
C.Baudouin;L.Bensoussan;P.Hamard;C.Creuzot-Garcher;P.J.Pisella;J.M.Warnet;F.Brignole
..............page:84-85
OPTIC DISC MORPHOMETRY BY WARPING METHOD
G.N.Macovei;C.Romanescu;C.Constantin
..............page:84-84
BETAXOLOL DISTRIBUTES TO THE HUMAN RETINA AND OPTIC NERVE HEAD AT PHARMACOLOGICALLY ACTIVE LEVELS AFTER CHRONIC TOPICAL OCULAR ADMINISTRATION OF BETOPIC S
G.Hollo;J.T.Whitson;R.Faulkner;M.Curtis;H.Wieland;L.De Santis;B.McCue;J.T.Przydryga;D.C.Dahlin
..............page:83-83
EARLY CLINICAL RESULTS FOR A NOVEL PHASE I TRABECULAR BYPASS MICRO STENT
D.Spiegel;W.Wetzel;R.Hill
..............page:83-83
THE LONG TERM RESULTS OF SELECTIVE LASER TRABECULOPLASTY (SLT)
T.Tuna;P.Demirbay;E.Sen;G.Koklu;E.Firat;F.Ural
..............page:75-75
ELEVATED AQUEOUS HUMOR NITRIC OXIDE LEVELS DIFFER IN PATIENTS WITH DIFFERENT TYPES OF GLAUCOMA
U.Eksioglu;B.Tunctan;I.Yalvac;A.Babul;I.Midillioglu;S.Duman
..............page:74-75
THE EFFECTIVE VISUAL FIELD STRATEGY FOR NORMAL PEDIATRIC POPULATION
Y.Akar;I.Yucel;A.Yilmaz
..............page:74-74
LOW OR UNRECORDABLE PULSATILE OCULAR BLOOD FLOW MAY BE RELATED TO SEVERE STENOSIS OF THE IPSILATERAL INTERNAL CAROTID ARTERY
Y.Barkana;A.Harris;L.Hefez;M.Zaritski;D.Chen;I.Avni
..............page:74-74
THE EFFECT OF CORNEAL DRYING ON CENTRAL CORNEAL THICKNESS
V.Dayanir;R.Sakarya;A.Topaloglu;E.Kir;T.Aktunc;S.B.Ozkan
..............page:73-74
THE PRESSURE LOWERING EFFECTS OF BIMATOPROST ONCE DAILY AT BEDTIME IN PATIENTS WHO FAILED PREVIOUS LATANOPROST TREATMENT
L.Magaoho;L.J.Katz;W.C.Steinmann;J.S.Myers;G.L.Spaeth;D.Rhee;R.L.Wilson;M.Moster;C.Schmidt
..............page:73-73
EFFECT OF RALOXIFENE ON RETROBULBAR HEMODYNAMICS IN POSTMENOPAUSAL WOMEN
R.Rachmiel;M.Zalish;B.Kaplan;L.Mc Cranor;L.Kageman;A.Pollack;A.Harris
..............page:73-73
COMPARATIVE EVALUATIVE STUDY OF EFFICIENCY AND SAFETY OF THE USAGE OF TOPICAL CARBOANHYDRASE INHIBITORS
T.E.Yegorova;T.V.Stavitskaya;A.A.Hlobystov
..............page:72-72
VISCOCANALOSTOMY AND T-FLUX IMPLANTATION IN THE MANAGEMENT OF GLAUCOMA ASSOCIATED WITH STURGE-WEBER SYNDROME
U.Gunenc;Z.Ozbek;T.Ucar
..............page:76-76
TOPICAL CARTEOLOL WITH AND WITHOUT BENZALKONIUM CHLORIDE: EFFECT ON THE OCULAR SURFACE AND INTRAOCULAR PRESSURE
V.Papa;A.Scuderi;P.Russo;G.Milazzo
..............page:75-76
NEEDLING REVISION WITH PREOPERATIVE INJECTION OF MITOMYCIN-C FOR FAILED FILTERING BLEBS
Y.Y.Chen
..............page:75-75
COMPARISON OF TOPICAL LATANOPROST 0.005 % AND BRIMONIDINE 0.2% EYE DROPS IN THE ADJUNCTIVE TREATMENT OF PATIENTS WITH OPEN ANGLE GLAUCOMA
T.Simsek;A.Batman;U.Elgin;M.Alper;O.Zilelioglu
..............page:75-75
THE PHARMACOKINETIC QUESTION OF TOPICAL NEURO-PROTECTIVE AGENTS: HOW DOES A TOPICALLY APPLIED DRUG PENETRATE TO THE BACK OF THE EYE?
M.Abdulrazik;S.Tamilvanan;S.Benita
..............page:93-94
ADVANTAGES OF A NEW EXCIMER LASER FOR GLAUCOMA SURGERY
N.N.Ereskin;K.P.Takhchidi;S.K.Vartapetov;A.V.Doga;D.A.Magaramov;T.V.Sokolovskaya
..............page:93-93
BUT WHY NOT JUST DRUG RX FOR SC?
P.L.Kaufman
..............page:93-93
THE CONCEPTUAL FRAMEWORK OF AUTOMATED PERIMETRY
L.Zborowski-Naveh
..............page:93-93
AN AUTOMATED PERIMETRY READING CENTER FOR A LARGE METROPOLITAN AREA
L.Zborowski-Naveh;M.Lusky;D.Weinberger;D.D.Gaton
..............page:92-93
RACIAL DIFFERENCES OF OPTIC DISC TOPOGRAPHY IN OCULAR HYPERTENSIVE EYES: RESULTS FROM THE CONFOCAL SCANNING LASER OPHTHALMOSCOPY ANCILLARY STUDY TO THE OCULAR HYPERTENSION TREATMENT STUDY
L.M.Zangwill;R.N.Weinreb;C.C.Berry;A.R.Smith;K.A.Dirkes;A.L.Coleman;J.R.Piltz-Seymour;J.L.Liebmann;G.A.Cioffi;G.Trick;J.D.Brandt;M.O.Gordon;M.A.Kass
..............page:92-92
CONFOCAL MICROSCOPY IN THE STUDY OF PRIMARY CONGENITAL GLAUCOMA
L.Arrico;S.Donati;M.Trani;L.Colella;R.Losciale;A.Missiroli
..............page:91-92
CENTRAL CORNEAL THICKNESS IN BLACK AND WHITE BRAZILIAN CATIENTS
M.Hatanaka;J.F.Lopes;G.A.S.Firmo;J.A.Ferreira;R.Susanna-Jr
..............page:63-63
SLIT-LAMP EXTERNAL NEEDLE REVISION WITH SUBCONJUNCTIVAL 5-FLUOROURACIL FOR DELAYED FAILURE OF TRABECULECTOMY
P.P.Syam;C.Atherly;N.Anand
..............page:61-61
INFLUENCE OF WATER DRINKING TEST ON CENTRAL CORNEAL THICKNESS
M.Hatanaka;J.A.Ferreira;G.A.S.Firmo;J.F.Lopes;I.R.Elias;C.Morita;R.Susanna-Jr
..............page:63-63
CORRELATION BETWEEN ASYMMETRIC GLAUCOMATOUS VISUAL FIELD DAMAGE AND ASYMMETRIC WATER DRINKING TEST RESPONSE
R.Susanna-Jr;M.Hatanaka;A.G.Pinheiro;C.Morita
..............page:63-63
AB EXTERNO DRUG DELIVERY TO SCHLEMM′S CANAL
P.Challa;Y.Wang;C.W.Lin;F.Yuan;D.L.Epstein
..............page:62-63
COMPARISON OF THE EFFICACY AND SAFETY OF TRAVOPROST 0.004% COMPARED TO LATANOPROST 0.005% WHEN ADDED TO A TOPICAL BETA-ADRENERGIC BLOCKER IN PATIENTS WITH PRIMARY OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTENSION
P.Frezzotti;R.Ciappetta;S.Cini;S.de Robertis;A.Caporossi
..............page:62-62
EVALUATION OF TWO HUMPHREY PERIMETRY PROGRAMS; FULL THRESHOLD AND SITA-STANDARD TESTING STRATEGY FOR LEARNING EFFECT IN NORMAL SUBJECTS
O.Yenice;A.Temel;F.Orucoy
..............page:61-62
STUDY OF PERIPAPILLRY NERVE FIBER LAYER MEASUREMENT BY SCANNING LASER POLARIMETRY BETWEEN EYES OF GLAUCOMA SUSPECTS AND THOSE WITH GLAUCOMATOUS VISUAL FIELD DEFECT
M.S.Kook;S.Kim;J.Choi;H.Hong;W.Kangz
..............page:61-61
ETHNICITY DEMOGRAPHICS OF ACUTE ANGLE CLOSURE GLAUCOMA IN A MULICULTURAL CONURBATION
S.P.Kelly;V.Sudha;C.Maw;J.R.Gandhewar
..............page:67-67
INFLUENCE OF MEDICAL THERAPY ON VISUAL FUNCTIONS HYDRODYNAMICS AND BLOOD-FLOW IN THE OPTIC NERVE IN PATIENTS WITH GLAUCOMA IN COMBINATION WITH MYOPIA
N.Makashova
..............page:58-58
SIX MONTHS EXPERIENCE WITH TRAVOPROST 0.004% (Travatan, ALCON) IN THE TREATMENT OF PRIMARY OPEN ANGLE GLAUCOMA
N.H.Petkova;C.B.Rankova;B.D.Angnelov
..............page:58-58
COMPARISON OF THE FREQUENCY DOUBLING PERIMETRY SCREENING ALGORITHM AND PERIPAPILLARY NERVE FIBER LAYER THICKNESS PARAMETERS AS MEASURED BY SCANNING LASER POLARIMETRY IN PATIENTS WITH HIGLY SUSPECTED GLAUCOMA
M.S.Kook;S.Kim;J.Choi;H.Hong;W.Kang
..............page:57-58
AQUEOUS VALVES AND PULS A TILE AQUEOUS OUTFLOW: NEW TREATMENT TARGETS IN GLAUCOMA
M.Johnstone;R.Stegmann
..............page:57-57
COMPARISON OF SELF-INSTILLATION FROM MULTI-DOSE AND SINGLE DOSE EYE DROP BOTTLES IN ELDERLY PATIENTS
O.Kayikcioglu;T.Erakagun;S.Egilmez;C.Akkin
..............page:57-57
CHANGES IN OPHTHALMIC ARTEY FLOW PARAMETERS BY EXTERNAL PRESSURE IN NORMAL AND GLAUCOMATOUS EYES
O.Kayikcioglu;I.Yorulmaz;C.Guler
..............page:56-57
THE IMPACT OF ACUTE DYNAMIC EXERCISE ON INTRAOCULAR PRESSURE VARIATIONS: THE ROLE OF THE BETA-2-ADRENERGIC RECEPTOR POLYMORPHISM
N.Bekir;K.Gungor;H.Beydagi;S.Aynacioglu
..............page:56-56
RESULTS OF COMBINED TRABECULECTOMY AND PHACOEMULSIFICATION IN PSEUDOEXFOLIATION VERSUS NON-PSEUDOEXFOLIATION GLAUCOMA PATIENTS
G.Landa;A.Pollack;A.Marcovich;R.Rachmiel;M.Zalish
..............page:56-56
DOES THE SITE OF FILTRATION INFLUENCE THE MEDIUM TO LONG TERM INTRAOCULAR PRESSURE CONTROL FOLLOWING MICROTRABECULECTOMY?
S.V.Vernon;A.K.Negi;W.Kiel
..............page:66-67
DEEP SCLERECTOMY WITH HIALURONIC IMPLANT IN PSEUDOPHAKIC EYES
R.Leszczynski;A.Gierek-Lapinska
..............page:66-66
ELEVATION OF INTRAOCULAR PRESSURE (IOP) IN PATIENTS WITH ASYMMETRIC PRIMARY OPEN-ANGLE GLAUCOMA (POAG) IS ASSOCIATED WITH THEIR PREFERRED SLEEPING POSITION
S.F.Lerner;N.Chiari
..............page:66-66
INTRAOCULAR PRESSURE (IOP) VARIATIONS IN DIFFERENT POSITIONS IN PATIENTS WITH GLAUCOMA ASSOCIATED WITH EXFOLIATION SYNDROME (GXFS)
S.F.Lerner;D.Sivori
..............page:65-66
POSNER-SCHLOSSMAN SYNDROME: OUR EXPERIENCE
S.Jimenez-Carmona;A.M.Pedro
..............page:65-65
COMPARISION OF THE EFFICACY OF THE AHMED GLAUCOMA VALVE IMPLANT IN PATIENTS WITH NEOVASCULAR GLAUCOMA ACCORDING TO LENS PARAMETER
S.Kuyumcu;H.Bozkir;H.Horoz;H.H.Erbil
..............page:65-65
BRANCH RETINAL ARTERY OCCLUSION FOLLOWED BY SLP AND OCT: A CASE REPORT
G.H.Nouer;A.A.M.Rosa;M.Hatanaka;C.Morita;R.Susanna-Jr
..............page:65-65
FIRST POSTOPEARTIVE DAY INTRAOCULAR PRESSURE AS A PROGNOSTIC INDICATOR IN DEEP SCLERECTOMY
T.Shaarawy;J.Flammer;A.Mermoud
..............page:71-72
LONG-TERM RESULTS OF DEEP SCLERECTOMY WITH COLLAGEN IMPLANT
T.Shaarawy;K.Mansouri;A.Mermoud
..............page:71-71
HEADACHES AS THE PRESENTING SYMPTOM OF SUBACUTE ANGLE CLOSURE GLAUCOMA AN OVERLOOKED DIAGNOSIS
R.Nesher;E.Epstein;Y.Stern;E.Assia
..............page:70-71
LATANOPROST TREATMENT ONCE DAILY VS. WEEKLY REGIMEN
S.Kurtz;G.Shemesh
..............page:70-70
TRABECULECTOMY ASSOCIATED TO AN AHMED VALVE AND INTRAOCULAR TAMPONADE WITH SILICONE OIL
M.Celso;S.J.Remo
..............page:64-65
A FOUR-WEEK COMPARISON OF BIMATOPROST 0.03% AND BIMATOPROST 0.015% IN PATIENTS WITH ELEVATED INTRAOCULAR PRESSURE
J.A.Ferreira;G.A.S.Firmo;I.R.Elias;S.J.Khater;M.Hatanaka;R.Susanna-Jr
..............page:64-64
EFFECT OF TOPICALLY ADMINISTERED PROSTAMIDE AND PROSTAGLANDIN ANALOGS ON CENTRAL CORNEAL THICKNESS
M.Hatanaka;I.R.Elias;G.A.S.Firmo;J.A.Ferreira;S.J.Khater;A.G.Pinheiro;C.Morita;R.Susanna-Jr
..............page:64-64
CENTRAL CORNEAL THICKNESS IN WHITE AND YELLOW PATIENTS IN BRAZIL
M.Hatanaka;J.A.Ferreira;P.A.Florencia;C.Morita;R.Susanna-Jr
..............page:63-64
NON-CONVENTIONAL VACCINATION MINIMIZES RETINAL GANGLION CELL DEATH IN ACUTE AND CHRONIC GLAUCOMA
S.Bakalash;G.Ben Simon;S.Melamed;M.Schwartz
..............page:70-70
OBJECTIVE PERIMETRY WITH THE ACCUMAP CLINICAL APPLICATIONS
S.L.Graham;A.Klistoruer;C.Balachandran;I.Goldberg;A.Martins;F.Billson
..............page:69-70
COMPARISON BETWEEN LOSSES IN MACULAR TISSUE AND VISUAL FIELD DEFECTS IN GLAUCOMATOUS EYES
R.Zeimer;H.Jampel;H.Quigley;D.Friedman;N.Congdon;S.Vitale;C.Marks;F.Knezevich;Y.Ding
..............page:69-69
NEEDLING BLEB REVISION WITH MITOMYCIN-C IN FAILED TRABECULECTOMY WITH ENCAPSULATED BLEB
R.Zarei;S.Shahhoseini;F.Anvari;S.Nazari
..............page:69-69
TWO-YEAR COMPARISON OF BIMATOPROST WITH TIMOLOL IN PATIENTS WITH GLAUCOMA OR OCULAR HYPERTENSION
R.L.Gross;R.J.Noecker;J.Cheetham;P.Bernstein;S.M.Whitcup
..............page:68-69
A COMPARISON OF THE IOP-LOWERING EFFICACY OF BIMATOPROST AND LATANOPROST IN PATIENTS STRATIFIED BY BASELINE DIAGNOSIS: OCULAR HYPERTENSION VS GLAUCOMA
R.J.Noecker;P.Bernstein;A.L.Batoosingh;S.M.Whitcup
..............page:68-68
IOP LOWERING EFFICACY OF BIMATOPROST IN GLAUCOMA AND OCULAR HYPERTENSION PATIENTS NON-RESPON SIVE TO LATANOPROST
R.D.Williams
..............page:68-68
APON CONFIRMATION WITH SLO
S.Jimenez-Carmona
..............page:67-68
DOES COMMUNITY VISUAL FIELD SCREENING ENCOURAGE PARTICIPANTS TO HAVE EYE EXAMS?
S.L.Mansberger;C.A.Johnson;G.A.Cioffi
..............page:67-67
MANAGEMENT OF LEAKING FILTRATION BLEB WITH CYANOACRYLATE ADHESIVE
P.P.Hentova-Sencanic;Z.S.Micovic
..............page:60-61
EFFECT OF LATANOPROST MONOTHERAPY ON PRIMARY OPEN ANGLE GLAUCOMA AND PSEUDOEXFOLIATION
O.E.Abbasoglu;P.T.Atalar;E.Gursel
..............page:60-60
TREATMENT TABLES TO IMPROVE COMPLIANCE WITH GLAUCOMA TREATMENT
M.Zalish;R.Rachmiel;T.Blanco;E.Schechtman;Z.Ben-Natan;L.Sheli;A.Pollack
..............page:60-60
DEVELOPMENT OF DRY EYE SYNDROME AMONG PATIENTS IN CLIMACTERIC PERIOD TREATED WITH BETA-BLOCKERS
E.A.Egorov;N.V.Muratova
..............page:59-60
DIURNAL INTRAOCULAR PRESSURE VARIATION IN PSEUDOEXFOLIATION SYNDROME
O.Altintas;N.Yuksel;L.V.Karabas;Y.Caglar
..............page:59-59
CYSTOID MACULAR EDEMA ASSOCIATED WITH LATANOPROST
O.Ahintas;N.Yuksel;L.V.Karabas;G.Demirci
..............page:59-59
RETINAL NERVE FIBER LAYER MEASUREMENTS ARE NOT CHANGED FOLLOWING LASER IN-SITU KERATOMILEUSIS (LASIK) FOR HIGH MYOPIA AS MEASURED BY SCANNING LASER POLARIMETRY WITH CUSTOM COMPENSATION FOR ANTERIOR SEGMENT BIREFRINGENCE
N.T.Choplin;S.C.Schallhorn;D.Tanzer;J.L.Tidwell;Q.Zhou;M.Sinai
..............page:59-59
THE IMPORTANCE OF SIDE EFFECTS FOR COMPLIANCE IN THE TREATMENT OF GLAUCOMA
J.P.Nordmann
..............page:47-48
AHMED GLAUCOMA VALVE IMPLANTATION:ONE YEAR FOLLOW-UP
H.Eren;S.Bayraktar;C.Ozturk;O.F.Yilmaz
..............page:45-45
THE LONG-TERM EFFECTIVENESS OF TRABECULECTOMY IN PRIMARY OPEN ANGLE GLAUCOMA AND IN PSEUDOEXFOLIATIVE GLAUCOMA
I.Kocak-Midillioglu;I.Yalvac;U.Eksioglu;S.Duman
..............page:47-47
MANAGEMENT OF GLAUCOMA IN WEILL MARCHESANI SYNDROME
I.Kocak-Midillioglu;I.S.Yalvac;U.Eksioglu;B.S.Asian;S.Duman
..............page:47-47
COMPARISON OF THE EFFICACY OF THE FIXED-COMBINATION TIMOLOL/DORZOLAMIDE VERSUS CONCOMITANT ADMINISTRATION OF TIMOLOL AND DORZOLAMIDE
J.Bacharach;A.G.Iwach;M.F.Delgado
..............page:46-47
INCREASED LEVELS OF HELICOBACTER PYLORI IGG ANTIBODIES IN THE AQUEOUS AND SERUM OF PATIENTS WITH PRIMARY OPEN-ANGLE AND EXFOLIATION GLAUCOMA
J.Kountouras;N.Mylopoulos;A.G.P.Konstas;C.Zavos;D.Chatzopoulos;A.Boukla
..............page:46-46
INTRACTABLE GLAUCOMA OCCURING AFTER CATARACT SURGERY
H.I.Imamoglu;H.Erdol;N.Akyol;E.Dogus
..............page:46-46
THE GDX WITH VARIABLE CORNEA COMPENSATION (VCC)
H.G.Lemij;N.J.Reus
..............page:45-46
THE INFLUENCE OF MAGNESIUM ON OCULAR HEMODYNAMICS AND VISUAL FUNCTION IN GLAUCOMA PATIENTS
K.A.Mollenhauer;L.E.Pillunat;A.G.Boehm;M.F.Mueller;A.U.Koeller
..............page:55-56
ADENOSINE REDUCES INTRAOCULAR PRESSURE AND INCREASES OPTIC NERVE HEAD AND CHOROIDAL BLOOD FLOW IN HEALTHY HUMANS
E.Polska;P.Ehrlich;A.Luksch;G.Fuchsjager-Mayrl;L.Schmetterer
..............page:55-55
COMPARISON OF NON PENETRATING FILTRATION SURGERY FOR OPEN ANGLE GLAUCOMA WITH NON ABSORBABLE IMPLANT (T FLUX) VERSUS TRABECULECTOMY: A MULTICENTRIC STUDY
M.Dal Vecchio;B.Brogliatti;T.Rolle;F.M.Grignolo;L.Bauchiero;G.Vadala′;G.Caramello;M.Bruni;F.Molfino;E.Gremmo
..............page:55-55
SURGICAL TREATMENT OF EXFOLIATIVE GLAUCOMA
L.A.Voskanyan;Y.A.Baghdasaryan
..............page:54-54
COMPARATIVE STUDY OF HUMPHREY AUTOMATED PERIMETRY STRATEGIES CENTRAL 30-2 THRESHOLD TEST VERSUS CENTRAL 30-2 SITA STANDARD TEST
M.E.Gilbert-Lucido;G.Berumen-Alatorre;N.C.Ruiz-Quintero
..............page:54-54
RELIABILITY OF A AIR-PUFF NONCONTACT TONOMETER EVUALTED UNDER OPTIMAL STANDARDIZED TESTING ENVIRONMENT
M.Y.W.Kuo;Y.H.LEE
..............page:54-54
COMPARISON OF THE IOP-LOWERING EFFICACY OF BIMATOPROST 0.03% AND TRAVOPROST 0.004% IN PATIENTS WITH GLAUCOMA OR OCULAR HYPERTENSION
L.B.Cantor
..............page:53-54
PERIPAPILLARY RNFL EVALUATION WITH OCT AND GDX: CORRELATIONS BETWEEN THE TWO TECHNIQUES AND CORNEAL ARTIFACT EFFECT
E.Martini;G.Scarale;G.Lombardo;G.M.Cavallini
..............page:40-40
ACCURACY OF CLINICAL ESTIMATES OF INTRA OCULAR PRESSURE (IOP) WITH REGARD TO PACHIMETRY
F.Gaudenzi;M.Gu-denzoni;C.Linari;A.Rossi;C.A.Zotti
..............page:40-40
LASER DEEP SCLERECTOMY: 24 MONTHS FOLLOW-UP
E.V.Christodoulakis;V.P.Kozobolis;I.G.Pallikaris
..............page:39-40
AN EVALUATION OF BIMATOPROST MONOTHERAPY IN PATIENTS WITH GLAUCOMA OR OCULAR HYPERTENSION PREVIOUSLY TREATED WITH DUAL TIMOLOL/LATANOPROST THERAPY
L.Cantor;A.Batoosingh;P.Bernstein
..............page:53-53
IMPLANT OF EX-PRESS MINI GLAUCOMA SHUNT. SURGICAL TECHNIQUE AND RESULTS
M.L.Hernandez;D.Salom;F.Morais;A.Perez;M.Garcia
..............page:53-53
HIGH INTRAOCULAR PRESSURE IN PATIENT WITH TRAUMATIC HYPHEMA
M.Nili Ahmadabadi
..............page:52-52
A STUDY OF REPLACEMENT OF DUAL THERAPY WITH LATANOPROST IN PSEUDOEXFOLIATION GLAUCOMA
L.Bojic;Z.Mandic
..............page:52-52
OPTIC DISC PARAMETERS IN NORMAL HUMAN EYES USING THE DISCAM ACQUISITION SYSTEM. PRELIMINARY STUDY
C.Pappa;M.Aspiotis;G.Kitsios;M.Stefaniotou;K.Psillas
..............page:52-52
THE EFFICACY OF LASER GONIOPUNCTURE IN SHORT-AND LONGTERM PERIOD AFTER NONPENETRATING DEEP SCLERECTOMY
N.V.Strenev;A.I.Ovchinnikov
..............page:51-52
'TRADITIONAL' AND MICROINVASIVE NON-PENETRATING DEEP SCLERECTOMY -A COMPARISON OF RESULTS AND COMPLICATIONS
K.P.Takhcbidi;D.I.Ivanov;N.V.Strenev;D.B.Bardasov
..............page:51-51
CHRONIC ANGLE-CLOSURE GLAUCOMA MANAGEMENT BY RECONSTRUCTION OF THE ANTERIOR CHAMBER ANGLE
K.P.Takhchidi;D.I.Ivanov;N.V.Strenev
..............page:51-51
INNOVATIONS IN GLAUCOMA
D.L.Epstein
..............page:51-51
THE TIGR/MYOC MT.1 VARIANT ACCELERATES DISEASE PROGRESSION IN POAG PATIENTS: EFFECTS ON OPTIC DISC AND VISUAL FIELD MEASURES OF DAMAGE
J.R.Polansky;G.L.Spaeth;R.P.Juster
..............page:50-50
PLATEAU IRIS SYNDROME -15 CASES REPORT
K.Sakata;J.Arana;L.M.Sakata;D.R.Guerra
..............page:50-50
ERYTHROPOIETIN/ERYTHROPOIETIN RECEPTOR PLAY A ROLE IN ISCHEMIC PRE-CONDITIONING
D.M.Rosenbaum;S.Malhotra;S.Nijhawan;M.Singh;A.Junk;A.Steiner;P.S.Rosenbaum
..............page:36-36
THE EFFECT OF PHACOEMULSIFICATION ON THE INTRAOCULAR PRESSURE ANTERIOR CHAMBER DEPTH AND IRIDOCORNEAL ANGLE WIDTH IN SHORT AND MEDIUM TERM
C.Altan;S.Bayraktar;T.Altan;O.F.Yilmaz
..............page:35-36
THE EFFECT OF CYCLICAL MECHANICAL STRETCH ON DIFFERENTIAL GENE EXPRESSION IN LAMINA CRIBROSA CELLS
C.O′Brien;R.P.Kirwan;J.K.Crean;C.Fenerty;A.F.Clarke
..............page:35-35
SENSORINEURAL HEARING LOSS IN PSEUDOEXFOLIATION SYNDROME
B.Aydogan;N.Yuksel;G.Keskin;L.Karabas;Y.Caglar;A.Almac
..............page:35-35
THE EFFECT OF CAFFEINE ON RETROBULBAR HEMODYNAMICS
B.Aydogan;N.Yuksel;Y.Anik;O.Altintas;A.Demirci;Y.Caglar
..............page:35-35
BILATERAL CYSTOID MACULAR EDEMA AND LATANOPROST
J.Loscos Arenas;A.Parera Arasanz;J.Camara Hermoso
..............page:50-50
REGULATION OF HUMAN RETINAL BLOOD FLOW BY ENDOTHELIN-1
K.Polak;A.Luksch;B.Frabk;E.Polska;L.Schmetterer
..............page:49-50
EFFECT OF CATARACT SURGERY ON MICROTRABECULECTOMY FUNCTION
J.M.Koppens;S.A.Vernon
..............page:49-49
BLINDNESS INCIDENCE IN LITHUANIA
J.Neverauskiene;G.Chaleckiene;D.Baniuliene;A.Kalasauskiene
..............page:49-49
SCREENING FOR GLAUCOMA USING FREQUENCY DOUBLING TECHNOLOGY
L.Vancea;B.Gothlin;P.Wanger;L.Martin
..............page:48-49
METIPRANOLOL IS NEUROPROTECTIVE IN RETINAL ISCHAEMIA
K.G.Schmidt;N.N.Osborne;J.Melena;J.P.M.Wood;L.Pillunat
..............page:48-48
EXPERIENCE WITH THE PROVIEW EYE PRESSURE MONITOR
J.T.Wilensky
..............page:48-48
THE EFFECTS OF LONG-TERM SILDENAFIL TREATMENT ON INTRAOCULAR PRESSURE WHITE-ON-WHITE AND BLUE-ON-YELLOW HUMPHREY PERIMETRY
H.Oguz;A.Verit;T.Gurkan;H.Ciftci
..............page:45-45
LONG-TERM REDUCTION IN THE INTRAOCULAR PRESSURE BY LATANOPROST
H.Hara;H.Abe;M.Shirakashi;T.Fukuchi;K.Suda;J.Ueda;K.Yaoeda;Y.Tanaka
..............page:44-45
TRANSSCLERAL DIODE LASER CYCLOPHOTOCOAGULATION IN REFRACTORY GLAUCOMA
H.Deniz;M.E.Turacli;O.Tekeli;H.Gul;K.Gunduz;F.Karel;K.Duruk
..............page:44-44
DOES COLLAGEN PUNCTAL PLUGS HAVE PREVENTIVE EFFECT ON THE BRONCHOCONSTRICTION CAUSED BY TOPICAL TIMOLOL IN ASTHMATIC SUBJECTS?
I.Hepsen;H.Yilmaz;Z.Yildirim
..............page:43-44
NEW CILIARECTOM/TRABECULECTOMY PROCEDURE EFFECTIVE FOR DESPERATE GLAUCOMATOUS EYES:LATE RESULTS
G.Engin;G.Gulkilik;C.Yilmazli;K.Engin
..............page:43-43
PACHYMETRIC ANALYSIS IN PRIMARY OPEN ANGLE GLAUCOMA PSEUDOEXFOLIATIVE GLAUCOMA AND PSEUDOEXFOLIATIVE SYNDROME
A.Kocak Altintas;F.Cakici;F.G.Aslan;B.Ozkan;T.Takmaz;I.Can
..............page:30-30
CONJUNCTIVAL IMPRESSION CYTOLOGY AFTER GLAUCOMA FILTERING SURGERY
A.Clement Corral;M.A.Muriel Herrero;A.H.Estrada;M.A.Corral;G.Rebolleda;F.J.Munoz-Negrete;L.Rivas Jara
..............page:30-30
EFFECTIVENESS OF BIMATOPROST 0.03% (LUMIGAN) ON MEDICALLY UNCONTROLLED INTRAOCULAR PRESSURE
A.M.Carlsson;A.C.Crichton
..............page:29-30
BILATERAL OPHTHALMIC CAROTHID ANEURYSM THAT MIMICS NORMAL TENSION GLAUCOMA
G.Alfaro;F.Gil;J.Fromow;I.Ordonez;A.Katz
..............page:43-43
OCULAR SURFACE CHANGES INDUCED BY CARTEOLOL AND TIMOLOL
G.Milazzo;B.Carstocea;O.Gafencu;M.Armengioiu;P.Russo;V.Papa
..............page:43-43
THE EFFECT OF DORZOLAMIDE IN RAT RETINAL CAPILLARIES
F.Reber;R.H.W.Funk
..............page:42-43
FFICACY AND SAFETY OF PHACOEMULSIFICATION AND DEEP SCLERECTOMY COMPARED WITH PHACOTRABECULECTOMY
G.Rebolleda;J.Corcostegui Corrina;A.H.Estrada;F.J.Munoz-Negrete
..............page:42-42
PENETRATING DEEP SCLERECTOMY WITH T FLUX FOR NEOVASCULAR GLAUCOMA
E.Dahan
..............page:42-42
LIMITED CONTROLLED INFLAMMATION PROCESS IN THE TREATMENT OF GLAUCOMATOUS OPTIC NEUROPATHY
E.A.Yegorov;A.P.Nesterov
..............page:41-41
AN OVERALL TELEMEDICAL APPROACH TO REMOTE GLAUCOMA PATIENTS
G.Labiris;A.Petounis
..............page:41-41
INITIAL CLINICAL FEASIBILITY EXPERIENCE WITH A NEW PHASE I TRABECULAR BYPASS MICRO STENT
F.Gil-Carrasco;E.Salinas-VanOrman;R.A.Hill
..............page:40-41
ANALYSIS OF DIFFERENT RISK FACTORS IN PRIMARY OPEN ANGLE GLAUCOMA
F.De Gregorio;G.Stecchi;E.D′Ubaldo
..............page:39-39
ELECTRIC MAGNETIC NEUROSTIMULATIONS ARE REALLY NEUROPROTECTION
S.Anisimov;S.Anisimova
..............page:20-20
OCULAR BLOOD FLOW EVALUATION (POBF AND CDI) IN INJURED AND HEALTHY FELLOW EYES
E.Martini;M.Guiducci;G.P.Scarale;G.M.Cavallini
..............page:39-39
MEDIUM TERM OUTCOME OF NON-PENETRATING DEEP SCLERECTOMY (NPDS) COMPARED WITH TRABECULECTOMY
D.Chiselita;I.Antohi;R.Medvichi;C.Danielescu
..............page:38-39
CORRELATION OF QUANTITIVE NERVE FIBER LAYER MEASUREMENT WITH ⅥSUAL FIELD IN IDENTIFIYING EARLY GLAUCOMATOUS CHANGE
F.Ozturk
..............page:38-38
ULTRASOUND BIOMICROSCOPY IMAGES: LONG TERM RESULTS AFTER DEEP SCLERECTOMY
S.Roters;C.Schnyder;A.Mermoud;G.Krieglstein;D.Kazakova
..............page:38-38
CARDIORESPIRATORY EFFECTS OF LA TANOPROST AND BETAXOLOL IN PA TIENTS WITH PRIMARY OPEN ANGLE GLAUCOMA
E.F.Erkin;P.Celik;O.Kayikcioglu;H.Deveci;A.Sakar
..............page:37-38
NATIONAL SURVEY OF ANTIMETABOLITE USE IN GLAUCOMA SURGERY IN THE UNITED KINGDOM
D.Siriwardena;B.Edmunds;R.P.L.Wormald;P.T.Khaw
..............page:37-37
ELECTRON MICROSCOPY OF THE LENS IN PATIENTS WITH GLAUCOMA AND CATARACT
F.Karel;E.Turacli;B.Can;O.Tekeli;B.Sabuncuoglu;M.Tekelioglu;K.Duruk;S.Dogan
..............page:37-37
HEIDELBERG RETINA ANGIOGRAPH (HRA) AS A USEFUL TOOL FOR RETINAL NERVE FIBER LAYER EXAMINATION
F.Vigasio;M.Bertelli;M.Cassamali;L.Rosa;F.Spedale
..............page:36-37
INTRAOCULAR PRESSURE DECREASE IN SURGICAL TREATMENT FOR CONGENITAL GLAUCOMA
A.Lauretti;L.Silva Costa;C.Lau-retti
..............page:36-36
SCHLEMM′S CANAL: ANATOMY AND FUNCTION: DOES SC CONTROL OUTFLOW?
C.R.Ethier
..............page:32-32
COMPUTED TOMOGRAPHIC THICKNESS OF RETROBULBAR OPTIC NERVE IS DECREASED IN PATIENTS WITH GLAUCOMA AND IS NEGATIVELY CORRELATED WITH DISEASE SEVERITY
C.Evereklioglu
..............page:31-32
SHORTTERM EFFECT OF LATANOPOST ON INTRAOCULAR PRESSURE AND OCULAR CIRCULATION IN OCULAR HYPERTENSION
Cengiz Akarsu;Y.K.Bilgili;P.Taner;B.Unal;A.Ergin
..............page:31-31
SCANNING LASER POLARIMETRIC FOLLOW-UP OF TURKISH PATIENTS WITH OCULAR HYPERTENSION
B.Bozkurt;M.Irkec;A.Dogan;M.Orhan;E.Karaagaoglu
..............page:30-31
REGRESSION OF ANTERIOR SEGMENT NEOVASCULARISATION FOLLOWING CAROTID ENDARTERECTOMY IN A PATIENT SUFFERING FROM OCULAR ISCHAEMIC SYNDROME
C.Gutierrez;M.Moreno;J.M.Hernaez;F.Munoz
..............page:34-35
NONPENETRATING. GLAUCOMA SURGERY WITH SK-GEL IMPLANT VERSUS TRABECULECTOMY
C.Gutierrez;M.Moreno;C.Villada;R.Torres;F.Munoz
..............page:34-34
FREQUENCY DOUBLING TECHNOLOGY (FD) AS A SCREENING TOOL FOR GLAUCOMA IN AN OPTOMETRY PRACTICE(PRELIMINARY RESULTS)
A.Shaikh;J.Barber;B.James
..............page:34-34
ANALGESIC EFFECT OF CLONIDINE IN RETROBULBAR INJECTIONS ON BLIND GLAUCOMATOUS PAINFUL EYES
C.Lauretti;A.Lauretti-Filho;G.Lauretti;D.Felipe
..............page:33-34
EFFECT OF BIMATOPROST LATANO PROST TRAVOPROST AND UNOPROSTONE ON INTRAOCULAR PRESSURE AND ON OCULAR BLOOD FLOW
C.R.L.Figueiredo;E.R.Suzuki;J.B.B.Ribeiro;B.P.Figueiredo;W.D.Batista;J.Agostini
..............page:33-33
COMPARISON OF INTRAOCULAR PRESSURE CHANGES AFTER PHACOEMULSIFICATION IN EYES WITH AND WITHOUT PSEUDOEXFOLIATION
A.Kocak Altintas;S.Akdag;N.Onursever;D.Utkusolak;M.Sevuk;I.Can
..............page:33-33
COMPARISON OF EFFICACY OF APRACLONIDINE AND BRIMONIDINE ON OCULAR PRESSURE RISING THAT SEEN AFTER CATARACT SURGERY
A.M.Avunduk;Z.Kapicioglu;E.Dogus;N.Akyol;H.I.Imamoglu;H.Erdol
..............page:32-33
A MULTI-NATIONAL RETROSPECTIVE STUDY OF RESOURCE UTILIZATION ASSOCIATED WITH GLAUCOMA DISEASE PROGRESSION IN EUROPE
C.E.Traverso;S.Gandolfi;S.P.Kelly;The Glaucoma Outcomes Study Gr;J.G.Walt;P.Buchholz;J.J.Doyle;K.M.Amaya;S.V.Kotak
..............page:32-32
GLAUCOMA′S IMPACT ON QUALITY-OF - LIFE AND ITS RELATION TO CLINICAL INDICATORS
S.Chaturvedi;A.Mehrotra;S.Mittal;H.Bahadur
..............page:22-23
OPTICAL COHERENCE TOMOGRAPHY MEASUREMENT OF MACULAR AND NERVE FIBER LAYER THICKNESS IN NORMAL AND GLAUCOMATOUS HUMAN EYES
V.Guedes;J.S.Schuman;E.Hertzmark;G.Wollstein;A.Correnti;R.Mancini;D.Lederer;S.Voskanian;L.Velazquez;H.M.Pakter;T.Pedut-Kloizman;J.G.Fujimoto;C.Mattox;R.Susanna Jr
..............page:22-22
INTRAOCULAR PRESSURE CHANGES AFTER PHACOEMULSIFICATION OF THE EYES WITH PSEUDOEXFOLIATION SYNDROME
M.Soyler;E.Yildirim;M.Erbezci
..............page:22-22
DIODE LASER CYCLO-ABLATION IN SILICONE OIL GLAUCOMA
S.Lake;A.Rubinstein;B.James
..............page:21-22
CORRELATION OF FREQUENCY-DOUBLING PERIMETRY INDICES TO STRUCTURAL OPTIC NERVE HEAD PARAMETERS
A.Ferreras;J.M.Larrosa;V.Polo;L.E.Pablo;F.M.Honrubia
..............page:29-29
CLINICOPATHOLOGICAL STUDY OF IRIS HYPERPIGMENTATION FOLLOWING CHRONIC LATANOPROST ADMINISTRATION
A.Petounis;I.Ghiconti
..............page:29-29
COMPARISON OF THE EFFICACY AND SAFETY OF THE CLASSIC AND MODIFIED PHACODEEP SCLERECTOMY TO PHACOTRABECULECTOMY
A.Petounis
..............page:28-29
CONTACT DIODE LASER CYCLOPHOTOCOAGULATION VERSUS CYCLOCRYO THERAPY IN REFRACTORY GLAUCOMA
A.Abdollahi;R.Zareie;G.Fakhraie;H.Amini;M.Jabarvand
..............page:28-28
RELATIONSHIP BETWEEN PSEUDOEXFOLIATION SYNDROME AND POSTERIOR CAPSULE OPACIFICATION
O.Keskin N.Yuksel;L.V.Karabas;O.Altintas;Y.Caglar
..............page:28-28
A 3-MONTH RANDOMIZED CONTROLLED TRIAL OF BIMATOPROST (LUMIGAN) VERSUS TIMOLOL/DORZOLAMIDE (COSOPT) IN PATIENTS WITH GLAUCOMA OR OCULAR HYPERTENSION
A.Coleman;P.Bernstein;S.Whitcup
..............page:27-28
VISCOCANALOSTOMY AS A TREATMENT FOR THE DYSGENETIC GLAUCOMAS
A.Stangos;G.Sunaric-Megevand;F.Panarello;P.Leuenberger
..............page:27-27
THE EFFECT OF DIFFERENT TOPICAL BETABLOCKERS ON OCULAR HEMODYNAMICS AND OPTIC NERVE HEAD BLOOD FLOW IN GLAUCOMA PATIENTS
A.G.Boehm;A.U.Koeller;M.F.Mueller;K.A.Mollenhauer;L.E.Pillunat
..............page:27-27
TREATMENT OF ADVANCE GLAUCOMAS USING LEKSELL GAMMA KNIFE
J.Pilbauer;J.Pasta;R.Liscak;V.Vladyka
..............page:14-15
THE ROLE OF METALLOPROTEINASES IN THE PROCESS OF WOUND HEALING FOLLOWING FILTERING PROCEDURES FOR GLAUCOMA
G.Welsandt;A.Hueber;N.Kociok;J.M.Esser;A.M.Joussen;G.K.Krieglstein;H.Mietz
..............page:14-14
PARTIAL TENON′S CAPSULE RESECTION WITH ADJUNCTIVE MITOMYCIN C IN AHMED GLAUCOMA VALVE IMPLANT
S.J.Remo
..............page:20-20
DIURNAL INTRAOCULAR PRESSURE REDUCTION WITH LATANOPROST 0,005% COMPARED TO TIMOLOL MALEATE 0.5% AS MONOTHERAPY IN PATIENTS WITH EXFOLIATION GLAUCOMA
A.G.P.Konstas;N.Mylopoulos;C.H.Karabatsas;V.P.Kozobolis;S.Diafas;P.Papapanos;W.C.Stewart
..............page:26-27
MITOMYCIN-C AUGMENTED TRABECOLECTOMY IN REFRACTORY DEVELOPMENTAL GLAUCOMA: LONG-TERM RESULTS WITH DIFFERENT CONCENTRATIONS
A.Ozkiris;N.Tamcelik
..............page:26-26
EXFOLIATION SYNDROME AND MORPHOLOGICAL APPEARANCE OF CON-JUNCTIVAL GOBLETS CELLS
V.P.Kozobolis;I.Naoumidou;E.Christodoulakis;I.G.Pallikaris
..............page:25-26
INFLUENCE OF CATARACT SURGERY AND INTRAOCULAR LENS IMPLANTATION ON RETINAL NERVE FIBER LAYER THICKNESS AS MEASURED BY SCANNING LASER POLARIMETRY
T.Trabucco;G.Ruggeri;D.Sisto;M.Vetrugno;C.Sborgia
..............page:25-25
FRANK -KAMENETSKI GLAUCOMA
T.N.Urieva;A.Chtchouko;L.T.Chekmareva;V.V.Malyshev
..............page:25-25
DEVELOPMENT MECHANISMS OF PIGMENTARY DISPERSION SYNDROME AND PIGMENT GLAUCOMA
T.N.Urieva;A.G.Chtchouko;V.V.Malyshev
..............page:24-25
EFFICACY OF SELECTIVE LASER TRABECULOPLASTY IN THE TREATMENT OF PRIMARY OPEN-ANGLE GLAUCOMA
T.Gracner
..............page:24-24
MATRIX METALLOPROTEINASE INHIBITION: A NEW APPROACH TO THE REDUCTION OF POST-OPERATIVE SCARRING FOLLOWING EXPERIMENTAL GLAUCOMA FILTRATION SURGERY
T.T.L.Wong;A.L.Mead;P.T.Khaw
..............page:24-24
VISCOCANALOSTOMY AND PHACOVISCOCANALOSTOMY: RESULTS OF CASES WITH AND WITHOUT IMPLANTS
U.Gunenc;Z.Ozbek;T.Ucar
..............page:23-24
EXPERIMENTAL BASIS OF NONABSORBED COLLAGEN IMPLANT APPLICATION IN SURGICAL TREATMENT OF GLAUCOMA
S.Anisimova;S.I.Anisimov;A.Panasuk;E.larionov
..............page:23-23
NON-PENETRATING DEEP SCLERECTOMY AND CATARACT EXTRACTION IN TERMS OF MOBILE CLINIC ON RIVER SHIPBORD AND MICROBUS TRAVELLING
S.Anisimova;S.I.Anisimov
..............page:23-23
LONG TERM INTRAOCULAR PRESSURE CONTROL FOLLOWING ANTIMETABOLITE ENHANCED SMALL FLAP TRABECULECTOMY (MICROTRABECULECTOMY) IN NTG AND IN EYES AT INCREASED RISK OF FAILURE
S.A.Vernon;R.Hamilton;J.Bhargava;A.Bhan
..............page:21-21
PROTECTIVE EFFECTS OF ISCHEMIC PRECONDITION ON RETINAL ISCHEMIA/REPERFUSION INJURY IN RATS
D.Ozbay;S.Ozden;S.Muftuoglu;F.Kaymaz;V.Yaylali;C.Yildirim;S.Tatlipinar
..............page:21-21
CORRELATION BETWEEN FUNCTIONAL AND STRUCTURAL LOSS IN GLAUCOMA
R.Sampaolesi;P.Brusini;J.R.Sampaolesi
..............page:20-21
EFFECTS OF NOCTURNAL LOW -DOSE PILOCARPINE ADMINISTRATION AGAINST PLATEAU IRIS CONFIGURATION AFTER LASER IRIDOTOMY
J.Ueda;Y.Tanaka;T.Fukuchi;K.Suda;A.Ohta;K.Yaoeda;H.Hara;M.Shirakashi;H.Abe
..............page:19-20
TRANSCONJUNCTIVAL OOZING AFTER GLAUCOMA SURGERY
N.Anand;P.P.Syam;C.Atherley
..............page:19-19
AFRICAN AMERICAN HEALTH DISPARITIES: GLAUCOMA AS A CASE STUDY
O.Kosoko-Lasaki;M.Olivier
..............page:19-19
RESULTS AFTER 6 MONTHS OF NON PENENTRANTING DEEP SCLEROTOMY WITH (NEW) OF HEMA
Ma.A.Parera Arranz;J.De la Camara Hermoso;J.Loscos Arenas
..............page:18-18
NEUROPROTECTIVE EFFECT OF MEMANTINE IN DIFFERENT GANGLION CELL INJURY MODELS
L.A.Wheeler;E.WoldeMussie;G.Ruiz
..............page:17-18
RELATIONSHIP BETWEEN OPTIC NERVE HEAD MICROCIRCULATION AND VISUAL FIELD LOSS IN GLAUCOMA
K.Yaoeda;M.Shirakashi;A.Fukushima;S.Funaki;H.Funaki;H.Abe
..............page:17-17
TRABECULECTOMY IN AXENFELD RIEGER SYNDROME. FUNTIONAL RESULT
E.Mengual-Verdu;K.Schargel;J.R.Hueso-Abancens;J.Garcia-Sanchez;J.Placeres-Daban
..............page:17-17
COMPUTERIZED PERIMETER SBP - 3000.UTILITY IN DIAGNOSE CONTROL AND FOLLOWING OF GLAUCOMA.OUR EXPERIENCE.PRELIMINARY RESULTS
K.Schargel;E.Mengual-Verdu;J.R.Hueso-Abancens;J.Garci-a-Sanchez;J.Placeres-Daban
..............page:16-17
GLAUCOMA IN PATIENT WITH STURGE-WEBER SYNDROME
J.F.Ramos Lopez;E.Palacios Pozo;A.Lanzagorta Aresti;E.Vila Mascarell;A.Illueca Gil;J.L.Menezo Rozalen
..............page:16-16
ESTIMATION THE EFFICACY WITH DEEP SCLERECTOMY IN GLAUCOMA SURGERY TREATMENT AT YEAR OF SURGERY
J.F.Ramos Lopez;E.Palacios Pozo;A.Lanzagorta Aresti;E.Vila Mascarell;A.Illueca Gil;J.L Menezo Rozalen
..............page:16-16
AHMED GLAUCOMA VALVE IMPLANT VERSUS SINGLE PLATE MOLTENO IMPLANT IN NEOVASCULAR GLAUCOMA
I.Yalvac;E.Caylak;U.Eksioglu;I.Midilliogln;S.Duman
..............page:16-16
IRIS BEHAVIOUR AFTER YAG LASER IRIDOTOMY IN A CASE OF PIGMENTARYB DISPERSION SINDROME PHOTODOCUMENTED WITH ARTEMIS ULTRALINK SCAN
J.Hoyos-Chacon;M.Cigales;J.E.Hoyos
..............page:15-16
NON PENETRATING GLAUCOMA SURGERY: COMPARISON OF ITS EFFICACY AND LONGEVITY WITH AND WITHOUT A NON -ABOSRBABLE HYDROPHILIC IMPLANT
E.Dahan;E.Ravinet;G.J.Ben Simon;A.Mermoud
..............page:15-15
SCANNING LASER DOPPLER FLOWMETRY OF NON PERFUSED REGIONS OF THE OPTIC NERVE HEAD IN GLAUCOMATOUS PATIENTS
G.J.Ben Simon;I.Moroz;M.Goldenfeld;S.Melamed
..............page:15-15
EFFICACY AND SAFETY OF BIMATOPROST IN PATIENTS WITH UNCONTROLLED GLAUCOMA ON MAXIMAL TOLERABLE MEDICAL THERAPY
M.Vetrugno;C.Sborgia;E.Balestrazzi;C.Bianchi;A.Caporossi;M.Nardi;A.Rapisarda;G.Tassinari;L.Zeppa;M.Bartolomei;S.di Staso;P.Frezzotti;G.Laffi;L.Marino
..............page:18-19
GLAUCOMA TOPICAL MEDICATIONS - HOW SAFE IS THE STERILITY FACTOR FOR CHRONIC USERS
Y.Porges;L.Rotkoff;S.Cohen
..............page:18-18
INTERPRETATION OF VITREOUS OPACITY ARTIFACTS OF THE GDX NERVE FIBER ANALYSER (NFA) RESULTS
M.L.Alimgil;O.Beniah
..............page:7-8
A STUDY OF THE EFFICACY AND SAFETY OF AZOPT
V.P.Erichev;J.N.Lovpache;O.M.Filippova
..............page:7-7
SEX DIFFERENCES IN PULSE AMPLITUD ND PULSATIL OCULAR BLOOD FLOW BETWEEN HEALTHY EYES AND WITH POAG
G.Alfaro;J.Jimenez-Roman;M.Moreno;J.Fromow;M.E.Ayala
..............page:7-7
ACUTE ULTRASTRUCTURAL CHANGES OF THE TRABECULAR MESHWORK AFTER SELECTIVE LASER TRABECULOPLASTY AND LOW POWER ARGON LASER TRABECULOPLASTY
B.Cvenkel;A.Hvala;M.Zupan
..............page:6-7
TRABECULECTOMY WITH ABSORBABLE AND NONABSORBABLE SUTURES OF THE SCLERAL FLAP IN PRIMARY OPEN ANGLE GLAUCOMA
B.J.Anguelov
..............page:6-6
SHOULD ALL POST TRABECULECTOMY HEMORRHAGIC KISSING CHOROIDALS BE DRAINED?
A.Aminlari
..............page:6-6
THE USE OF RELEASABLE SUTURES IN FILTRATION SURGERY REDUCES EARLY POST OPERATIVE COMPLICATIONS
A.Robinson;N.Blumberg;M.Lusky;D.Weinberger
..............page:5-6
VARIOUS MECHANISMS RELATED WITH ANGLE CLOSURE GLAUCOMA IN NANOPHTHALMOS
T.Fukuchi;J.Ueda;T.Nakatsue;K.Suda;Y.Tanaka;K.Yaoeda;H.Hara;M.Shirakashi;H.Abe
..............page:5-5
COMBINED TREATMENT OF NEOVASCULAR GLAUCOMA
A.M.Bessmertny;V.P.Erichev;O.V.Robustova
..............page:5-5
DETECTION OF GLAUCOMA WITH GDX ACCESS
M.Shirakashi;K.Yaoeda;S.Funaki;H.Funaki;T.Nakatsue;A.Fukushima;H.Abe
..............page:4-5
DEEP SCLERECTOMY AS A POTENTIAL CHOICE FOR EXFOLIATIVE GLAUCOMA
V.P.Kozobolis;G.Maskaleris;E.Christodoulakis
..............page:4-4
CORRELATION BETWEEN CONVENTIONAL AUTOMATED PERIMETRY (24-2 SITA) AND FREQUENCY-DOUBLING TECHNOLOGY IN ADVANCED GLAUCOMA
F.J.Munoz-Negrete;J.Gonzalez Martin-Moro;J.Lara;G.Rebolleda
..............page:14-14
PRIMARY TRABECULECTOMY WITH BRIEF EXPOSURE TO MITOMYCIN
G.J.Ben Simon;Y.Glovinsky
..............page:13-14
DIFFERENCE IN PULSE AMPLITUD PER-FUSION PRESSURE AND PULSATIL OCULAR BLOOD FLOW BETWEEN HEALTHY INDIVIDUALS AND POAG PATIENTS IN MEXICO
G.Alfaro;J.Jimenez;M.Moreno;J.Fromow;M.E.Anaya
..............page:13-13
LEARNING EFFECT IN FREQUENCY DOUBLING PERIMETRY AS A FUNCTION OF AGE PERIMETRIC EXPERIENCE AND THE PRESENCE OR ABSENCE OF GLAUCOMA
G.P.Heeg;T.L.Ponsioen;N.M.Jansonius
..............page:13-13
NOVEL LMX MUTATION IN A SPANISH FAMILY WITH NAIL -PATELLA SYNDROME
E.Milla;C.Verges;H.Assaf;M.Maseras;J.Marin;M.Martinez-Gimeno;M.J.Gamundi;I.Hernan;M.Carballo
..............page:13-13
DETECTION OF HERPES SIMPLEX VIRUS IN IRIS SPECIMENS FROM PATIENTS WITH PSEUDOEXFOLIATION SYNDROME
E.T.Detorakis;V.P.Kozobolis;I.G.Pallikaris;D.A.Spandidos
..............page:12-12
A CORRECTION FORMULA FOR THE REAL IOP AFTER LASIK
D.Sandner;L.E.Pillunat;K.Pollack;M.Kohlhaas;E.Spoerl
..............page:12-12
PHACOLYTIC GLAUCOMA DIANOSIS AND TREATMENT
D.Dieu
..............page:11-12
GLAUCOMATOUS OPTIC DISC MORPHOMETRY BY WARPING METHOD
C.C.Romanescu;C.P.Constantin;G.N.S.Macovei
..............page:11-11
GLAUCOMA SCREENING IN A HISPANIC POPULATION
F.Gomez Goyeneche;S.Belalcazar
..............page:11-11
TOPOGRAPHICAL CHANGES AFTER PHACOEMULSIFICATION AND DEEP SCLERECTOMY
J.Corcostegui Cortina;A.H.Estrada;F.J.Munoz-Negrete;G.Rebolleda
..............page:10-10
TOPOGRAPHIC CONCORDANCE BETWEEN SHORT WAVE AUTOMATED PERIMETRY AND FREQUENCY DOUBLING TECHNOLOGY IN OCULAR HYPERTENSION
A.Mahfud;J.Gonzalez Martin-Moro;M.A.Castejon;M.A.Teus;G.Rebolleda;F.J.Munoz-Negrete
..............page:10-10
EVALUATION OF GONIOTOMY AND TRABECULOTOMY PROCEDURES IN CONGENITAL GLAUCOMA
A.Ozcan;N.Ozdemir
..............page:10-10
THYMULIN AND NERVE GROWTH FACTOR (NGF) LEVELS IN PATIENTS WITH OPEN ANGLE GLAUCOMA (OAG)
B.Noureddin;B.Safieh-Garabedian
..............page:9-10
SECONDARY GLAUCOMA IN PATIENTS WITH UVEITIS
Y.Ozdemir
..............page:9-9
PRIMARY TRABECULECTOMY WITH LOW -DOSE POST -OPERATIVE MITOMYCIN
H.F.Mietz;P.C.Jacobi;G.Welsandt;G.K.Krieglstein
..............page:9-9
TOWARDS AN OPTIMAL ALGORITHM FOR THE INTERPRETATION OF FREQUENCY DOUBLING PERIMETRY
R.P.H.M.Muskens;G.P.Heeg;N.M.Jansonius
..............page:8-9
MANAGEMENT OF INTRAOCULAR PRESSURE FOLLOWING UNSUCCESSFULL TRABECULECTOMY: A RANDOMISED COMPARATIVE STUDY OF 5 -FLUOROURACIL VERSUS MEDICAL THERAPY
P.Ferreri;M.Vetrugno;A.Montepara;F.Cantatore;C.Sborgia
..............page:8-8
PSEUDOEXFOLIATION SYNDROME IN A JAPANESE POPULATION: THE HISAYAMA STUDY
M.Miyazaki;T.Kubota;H.Nakamura;M.Kubo;Y.Kiyohara;T.Ishibashi
..............page:8-8
THE EFFECT OF THE LEVELS OF THE VASCULAR ENDOTHELIAL GROWTH FACTOR IN OCULAR FLUID OF PATIENTS WITH NEOVASCULAR GLAUCOMA ON THE NEOVASCULARIZATION OF IRIS
W.Xinshun;L.Ruifang
..............page:4-4
ADHERENS JUNCTION IN SCHLEMM &# 8217; S CANAL: A NOVEL TARGET FOR GLAUCOMA THERAPY
W.D.Stamer;A.G.Burke;S.Kaochar;E.T.O′Brien;R.L.Heimark
..............page:3-4
HISTOLOGY OF THE IRIS OF EYES UNDER CHRONIC LATANOPROST THERAP
M.A.Teus;E.Arranz-Marquez;M.A.Saornil;M.C.Mendez
..............page:3-3
ZONA GLAUCOMA DIAGNOSIS AND MANAGEMENT
D.Dieu
..............page:3-3
SELECTIVE LASER TRABECULOPLASTY:A NEW APPROACH TO OPEN ANGLE GLAUCOMA MANAGEMENT
M.Nagar;F.Howes
..............page:3-3
DLK-LIKE REACTION DEVELOPING AFTER POST-LASIK STEROID INDUCED ELEVATION OF IOP (PSEUDO DLK)
Galal;A.Artola;J.Rodriguez-Prats;J.Belda
..............page:2-3
TRANSSCLERAL CYCLOPHOTOCOAGULATION WITH G-PROBE DIODE LASER IN COMPREHENSIVE TREATMENT OF REFRACTORY NEOVASCULAR GLAUCOMA (20 CASES)
I.Y.Buniatyan
..............page:2-2
HISTOLOGIC FINDINGS AFTER LASER TRABECULOPLASTY IN GLAUCOMATOUS EYES
D.H.Johnson;Mayo Clinic
..............page:1-2
NONCOMPLIANCE IN GLAUCOMA
K.S.Kooner;J.M.Vargas
..............page:1-1
COMPARATIVE ESTIMATION OF PRIMARY OPEN-ANGLE GLAUCOMA SURGICAL AND MEDICINES TREATMENT MINIMAL COST
A.V.Kuroyedov
..............page:1-1
A BLIND RANDOMIZED CROSS-OVER TRIAL COMPARING BETAXOLOL WITH TIMOLOL IN OPEN-ANGLE GLAUCOMA AND OCULAR HYPERTENSION
H.Mohammad-Rabie;J.Rajavi;M.Rahmati-kamel
..............page:1-1
© 2006 Oriprobe Information Services, Inc. All rights reserved
Tel: 1-519-977 9050 | Email:info@oriprobe.com
Home | Survey | Payment | Talks & Presentations | Job Opportunities